Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents | Zendy

Salvatore Cassese | Zendy; Petra Hoppmann | Zendy; Sebastian Kufner | Zendy; Robert A. Byrne | Zendy; Jens Wiebe | Zendy; Róisín Colleran | Zendy; Daniele Giacoppo | Zendy; Yukinori Harada | Zendy; KarlLudwig Laugwitz | Zendy; Heribert Schunkert | Zendy; Massimiliano Fusaro | Zendy; Adnan Kastrati | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents

Author(s) -

Salvatore Cassese,

Petra Hoppmann,

Sebastian Kufner,

Robert A. Byrne,

Jens Wiebe,

Róisín Colleran,

Daniele Giacoppo,

Yukinori Harada,

KarlLudwig Laugwitz,

Heribert Schunkert,

Massimiliano Fusaro,

Adnan Kastrati

Publication year - 2016

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.116.003698

Subject(s) - everolimus , bioresorbable scaffold , bare metal , medicine , drug eluting stent , biomedical engineering , cardiology , stent , restenosis , percutaneous coronary intervention , myocardial infarction

The performance of everolimus-eluting bioresorbable vascular scaffold (BVS) versus drug-eluting metallic stent (DES) in the same individual receiving multilesion percutaneous coronary intervention (PCI) remains poorly studied. This report investigates the intraindividual performance of BVS and DES in patients receiving multilesion PCI and follow-up angiography.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research